{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:26:24Z","timestamp":1795209984561,"version":"4.10.3"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>To assess the effects of adjunctive inhaled antibiotics in treating ventilator-associated pneumonia (VAP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>We searched PubMed, Web of Science, Embase, Cochrane Library, and ClinicalTrials.gov through May 31, 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY SELECTION:<\/jats:title>\n                    <jats:p>We included randomized controlled trials (RCTs) and nonrandomized studies comparing adjunctive inhaled antibiotics with placebo\/blank or IV antibiotics for VAP treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA EXTRACTION:<\/jats:title>\n                    <jats:p>Two groups independently screened studies, extracted data, and assessed risk of bias. Analyses used random effects models. Subgroup analyses, meta-regression, trial sequential analysis, and the Grading of Recommendations Assessment, Development, and Evaluation were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS:<\/jats:title>\n                    <jats:p>\n                      We included 32 RCTs in the primary analysis and 41 non-RCTs in sensitivity analysis. Compared with placebo\/blank, inhaled antibiotics significantly improved clinical cure (16 RCTs;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1425; risk ratio [RR], 1.24; 95% CI, 1.07\u20131.43) and reduced all-cause mortality (21 RCTs;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1855; RR, 0.84; 95% CI, 0.71\u20130.98), with consistent findings in sensitivity analyses including non-RCTs. These benefits were significant in VAP-only patients (clinical cure: 11 RCTs;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 775; RR, 1.29; 95% CI, 1.10\u20131.52 and all-cause mortality: 15 RCTs;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1152; RR, 0.77; 95% CI, 0.65\u20130.90), but not in studies including mixed pneumonia populations. Meta-regression confirmed VAP-only population as a significant effect modifier. Inhaled antibiotics also improved microbiological eradication (20 RCTs;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1805; RR, 1.42; 95% CI, 1.27\u20131.58) and reduced emergence of new drug resistance (four RCTs;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 182; RR, 0.20; 95% CI, 0.06\u20130.64). No differences were found in ICU length of stay, ventilator duration, or other adverse events. Compared with IV antibiotics, inhaled antibiotics shortened ventilator duration (three RCTs;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 322; mean difference, \u20132.11 d; 95% CI, \u20133.73 to \u20130.49 d), and reduced nephrotoxicity (three RCTs;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 292; RR, 0.42; 95% CI, 0.26\u20130.68).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Compared with placebo\/blank, adjunctive inhaled antibiotics improve clinical cure and microbiological eradication, and may reduce mortality, particularly in VAP-only patients. Exploratory analyses based on limited data suggest potential advantages over IV therapy, including shorter ventilator duration and lower nephrotoxicity, warranting further high-quality trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007072","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:00:52Z","timestamp":1773669652000},"page":"1293-1308","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Inhaled Antibiotics to Treat Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis"],"prefix":"10.1097","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-2920","authenticated-orcid":false,"given":"Shan","family":"Lyu","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Peking University People\u2019s Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit and Oxford NIHR Biomedical Research Centre, NDM Experimental Medicine, University of Oxford, Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Cardiopulmonary Sciences, Division of Respiratory Care, Rush University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjia","family":"He","sequence":"additional","affiliation":[{"name":"Division of Community Medicine and Public Health Practice, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Binzhou Medical University Hospital, Bingzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehrmann","sequence":"additional","affiliation":[{"name":"CHRU Tours, M\u00e9decine Intensive R\u00e9animation, CIC INSERM 1415, CRICS-TriggerSep F-CRIN research network, Tours, France."},{"name":"INSERM, Centre d\u2019Etude des Pathologies Respiratoires, U1100, Universit\u00e9 de Tours, Tours, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0121-1291","authenticated-orcid":false,"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiopulmonary Sciences, Division of Respiratory Care, Rush University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"R1-20260826","doi-asserted-by":"crossref","first-page":"107305","DOI":"10.1016\/j.ijid.2024.107305","article-title":"Preventing ventilator-associated pneumonia: A position paper of the International Society for Infectious Diseases, 2024 update.","volume":"151","author":"Rosenthal","year":"2025","journal-title":"Int J Infect Dis"},{"key":"R2-20260826","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2016.16226","article-title":"Trend in ventilator-associated pneumonia rates between 2005 and 2013.","volume":"316","author":"Metersky","year":"2016","journal-title":"JAMA"},{"key":"R3-20260826","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ajic.2023.12.019","article-title":"International Nosocomial Infection Control Consortium (INICC) report of health care associated infections, data summary of 45 countries for 2015 to 2020, adult and pediatric units, device-associated module.","volume":"52","author":"Rosenthal","year":"2024","journal-title":"Am J Infect Control"},{"key":"R4-20260826","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","article-title":"Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system.","volume":"173","author":"Zimlichman","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R5-20260826","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1473-3099(13)70081-1","article-title":"Attributable mortality of ventilator-associated pneumonia: A meta-analysis of individual patient data from randomised prevention studies.","volume":"13","author":"Melsen","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R6-20260826","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1164\/rccm.202202-0357OC","article-title":"Attributable mortality of ventilator-associated pneumonia among patients with COVID-19.","volume":"206","author":"Vacheron","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20260826","doi-asserted-by":"crossref","first-page":"106588","DOI":"10.1016\/j.ijantimicag.2022.106588","article-title":"Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia.","volume":"59","author":"Gkoufa","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R9-20260826","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/sur.2006.051","article-title":"Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: A pilot study.","volume":"8","author":"Hallal","year":"2007","journal-title":"Surg Infect (Larchmt)"},{"key":"R10-20260826","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/657242","article-title":"Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: A matched case-control study.","volume":"51","author":"Kofteridis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R11-20260826","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1469-0691.2009.03040.x","article-title":"Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: A comparative cohort study.","volume":"16","author":"Korbila","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R12-20260826","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2253-13-45","article-title":"Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: A retrospective study.","volume":"13","author":"Doshi","year":"2013","journal-title":"BMC Anesthesiol"},{"key":"R13-20260826","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT).","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"R14-20260826","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13054-024-05159-9","article-title":"Inhaled antibiotics for treating pneumonia in invasively ventilated patients in intensive care unit: A meta-analysis of randomized clinical trials with trial sequential analysis.","volume":"28","author":"Sella","year":"2024","journal-title":"Crit Care"},{"key":"R15-20260826","doi-asserted-by":"crossref","first-page":"102315","DOI":"10.1016\/j.pupt.2024.102315","article-title":"The efficacy and safety of inhaled antibiotics for pneumonia: A systematic review and meta-analysis.","volume":"86","author":"Zhang","year":"2024","journal-title":"Pulm Pharmacol Ther"},{"key":"R16-20260826","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12890-024-03032-7","article-title":"Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: Systematic review and meta-analysis.","volume":"24","author":"Buend\u00eda","year":"2024","journal-title":"BMC Pulm Med"},{"key":"R17-20260826","doi-asserted-by":"crossref","first-page":"107357","DOI":"10.1016\/j.ijantimicag.2024.107357","article-title":"Intravenous combined with aerosolised polymyxins vs intravenous polymyxins monotherapy for ventilator-associated pneumonia: A systematic review and meta-analysis.","volume":"64","author":"Tong","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"R18-20260826","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-024-05031-w","article-title":"Efficacy and safety of different polymyxin-containing regimens for the treatment of pneumonia caused by multidrug-resistant gram-negative bacteria: A systematic review and network meta-analysis.","volume":"28","author":"Zhou","year":"2024","journal-title":"Crit Care"},{"key":"R19-20260826","doi-asserted-by":"crossref","first-page":"154315","DOI":"10.1016\/j.jcrc.2023.154315","article-title":"Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis.","volume":"77","author":"Zhang","year":"2023","journal-title":"J Crit Care"},{"key":"R20-20260826","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcrc.2021.06.004","article-title":"Effectiveness and safety of adjunctive inhaled antibiotics for ventilator-associated pneumonia: A systematic review and meta-analysis of randomized controlled trials.","volume":"65","author":"Tang","year":"2021","journal-title":"J Crit Care"},{"key":"R21-20260826","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1038\/s41598-021-86342-8","article-title":"Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: A systematic review and meta-analysis of randomized controlled trials.","volume":"11","author":"Qin","year":"2021","journal-title":"Sci Rep"},{"key":"R22-20260826","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3390\/antibiotics13111099","article-title":"Evaluating the efficacy of inhaled colistin via two nebulizer types in ventilator-associated pneumonia: Prospective randomized trial.","volume":"13","author":"Huang","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"R23-20260826","doi-asserted-by":"crossref","first-page":"792","DOI":"10.5005\/jp-journals-10071-24767","article-title":"Polymyxin B plus aerosolized colistin vs polymyxin B alone in hospital-acquired pneumonia (\u201cAEROCOL\u201d study): A feasibility study.","volume":"28","author":"Ghosh","year":"2024","journal-title":"Indian J Crit Care Med"},{"key":"R24-20260826","first-page":"e49314","article-title":"The efficacy and safety of intravenous colistin plus aerosolized colistin versus intravenous colistin alone in critically ill trauma patients with multi-drug resistant gram-negative bacilli infection.","volume":"15","author":"Maan","year":"2023","journal-title":"Cureus"},{"key":"R25-20260826","first-page":"101249","article-title":"A prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled Tobramycin in patients with ventilator-associated pneumonia (iToVAP).","volume":"42","author":"Angermair","year":"2023","journal-title":"Anaesth Crit Care Pain Med"},{"key":"R26-20260826","first-page":"5213","article-title":"Efficacy and safety of combined parenteral and inhaled colistin versus systemic colistin in critical ill patients with ventilator associated pneumonia.","volume":"6","author":"Fatah","year":"2024","journal-title":"Afr J Bio Sc"},{"key":"R27-20260826","first-page":"76","article-title":"Administration of tobramycin aerosols in patients with nosocomial pneumonia: A preliminary study.","volume":"29","author":"Le Conte","year":"2000","journal-title":"Presse Med"},{"key":"R28-20260826","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/CCM.0b013e31817c0f9e","article-title":"Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit.","volume":"36","author":"Palmer","year":"2008","journal-title":"Crit Care Med"},{"key":"R29-20260826","first-page":"708","article-title":"Nebulized colistin in treatment of ventilator-associated pneumonia due to multi-drug resistance gram-negative bacteria: A clinical evaluation.","volume":"20","author":"Yu","year":"2010","journal-title":"Chin J Nosoco"},{"key":"R30-20260826","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dkq360","article-title":"Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.","volume":"65","author":"Rattanaumpawan","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R31-20260826","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00134-011-2420-0","article-title":"BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia.","volume":"38","author":"Niederman","year":"2012","journal-title":"Intensive Care Med"},{"key":"R32-20260826","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.201312-2161OC","article-title":"Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit.","volume":"189","author":"Palmer","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R33-20260826","first-page":"1319","article-title":"Clinical value of amikacin in treatment of Acinetobacter baumannii ventilator associated pnemonia.","volume":"27","author":"Zhu","year":"2015","journal-title":"Chin J Microecol"},{"key":"R34-20260826","doi-asserted-by":"crossref","first-page":"A380","DOI":"10.1186\/2197-425X-3-S1-A380","article-title":"Inhaled ceftazidime and amikacin versus inhaled colistin in the treatment of gram negative ventilator associated pneumonia.","volume":"3","author":"Nassar","year":"2015","journal-title":"Intensive Care Med Exp"},{"key":"R35-20260826","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.chest.2016.11.026","article-title":"A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of gram-negative ventilator-associated pneumonia: IASIS trial.","volume":"151","author":"Kollef","year":"2017","journal-title":"Chest"},{"key":"R36-20260826","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4103\/0366-6999.205846","article-title":"Aerosolized amikacin as adjunctive therapy of ventilator-associated pneumonia caused by multidrug-resistant gram-negative bacteria: A single-center randomized controlled trial.","volume":"130","author":"Liu","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"R37-20260826","first-page":"OA4655","article-title":"Eradication of MRSA ventilator-associated infection with inhaled vancomycin.","volume":"50","author":"Palmer","year":"2017","journal-title":"Eur Respir J"},{"key":"R38-20260826","first-page":"376","article-title":"Combined microbiological and clinical outcomes of short-term inhaled colistin adjunctive therapy in ventilator-associated pneumonia.","volume":"67","author":"Nassar","year":"2018","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"R39-20260826","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/sja.SJA_148_17","article-title":"Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia.","volume":"12","author":"Ammar","year":"2018","journal-title":"Saudi J Anaesth"},{"key":"R40-20260826","first-page":"66","article-title":"Effect of inhaled colistin on the treatment of ventilator-associated pneumonia due to multi-drug resistant acinetobacter.","volume":"18","author":"Moradi Moghaddam","year":"2019","journal-title":"Tanaffos"},{"key":"R41-20260826","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00134-019-05914-5","article-title":"Effect of adjunctive tobramycin inhalation versus placebo on early clinical response in the treatment of ventilator-associated pneumonia: The VAPORISE randomized-controlled trial.","volume":"46","author":"Stokker","year":"2020","journal-title":"Intensive Care Med"},{"key":"R42-20260826","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1473-3099(19)30574-2","article-title":"Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): A double-blind, randomised, placebo-controlled, phase 3, superiority trial.","volume":"20","author":"Niederman","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R43-20260826","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s42077-020-00098-3","article-title":"A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP).","volume":"12","author":"Fawy","year":"2020","journal-title":"Ain-Shams J Anesthesiol"},{"key":"R44-20260826","first-page":"108","article-title":"The potential role of aerosolized colistin in the ventilator-associated pneumonia management caused by multidrug-resistant gram negative bacteria: A randomized clinical trial.","volume":"9","author":"Feizabadi","year":"2021","journal-title":"J Pharma Care"},{"key":"R45-20260826","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2478\/jccm-2020-0044","article-title":"The susceptibility of MDR-K. pneumoniae to polymyxin B plus its nebulised form versus polymyxin B alone in critically ill South Asian patients.","volume":"7","author":"Hasan","year":"2021","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"R46-20260826","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4103\/aca.aca_81_21","article-title":"Randomized control study of nebulized colistin as an adjunctive therapy in ventilator-associated pneumonia in pediatric postoperative cardiac surgical population.","volume":"25","author":"Bharathi","year":"2022","journal-title":"Ann Card Anaesth"},{"key":"R47-20260826","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1164\/rccm.201011-1894OC","article-title":"Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa.","volume":"184","author":"Lu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R48-20260826","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-016-0127-7","article-title":"Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: A prospective, randomised trial.","volume":"6","author":"Abdellatif","year":"2016","journal-title":"Ann Intensive Care"},{"key":"R49-20260826","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/CCM.0000000000002695","article-title":"Nebulized versus IV amikacin as adjunctive antibiotic for hospital and ventilator-acquired pneumonia postcardiac surgeries: A randomized controlled trial.","volume":"46","author":"Hassan","year":"2018","journal-title":"Crit Care Med"},{"key":"R50-20260826","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/15321819.2019.1696818","article-title":"Comparison of two therapeutic approaches for the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter: A randomized clinical trial study.","volume":"41","author":"Khorvash","year":"2020","journal-title":"J Immunoassay Immunochem"},{"key":"R51-20260826","doi-asserted-by":"crossref","first-page":"e111084","DOI":"10.5812\/archcid.111084","article-title":"Comparison of inhaled colistin with inhaled amikacin-fosfomycin in the treatment of ventilator-associated pneumonia caused by extensively drug-resistant (XDR) acinetobacter: A clinical trial.","volume":"16","author":"Hakamifard","year":"2021","journal-title":"Arch Clin Infect Dis"},{"key":"R52-20260826","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/crj.13594","article-title":"Comparing inhaled colistin with inhaled fosfomycin\/tobramycin as an adjunctive treatment for ventilator-associated pneumonia: An open-label randomized controlled trial.","volume":"17","author":"Hakamifard","year":"2023","journal-title":"Clin Respir J"},{"key":"R53-20260826","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00134-020-05980-0","article-title":"Ventilator-associated pneumonia in adults: A narrative review.","volume":"46","author":"Papazian","year":"2020","journal-title":"Intensive Care Med"},{"key":"R54-20260826","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1164\/rccm.202402-0437CP","article-title":"Aerosolized antibiotic therapy in mechanically ventilated patients.","volume":"210","author":"Ehrmann","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R55-20260826","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13613-023-01147-4","article-title":"Aerosol therapy in adult critically ill patients: A consensus statement regarding aerosol administration strategies during various modes of respiratory support.","volume":"13","author":"Li","year":"2023","journal-title":"Ann Intensive Care"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:00:17Z","timestamp":1787770817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007072","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}